Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02475213 |
|---|---|
| Brief Title: | Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer |
| First Submitted : | June 16, 2015 |
| First Submitted that Met QC Criteria : | June 16, 2015 |
| First Posted : | June 18, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 22, 2021 |
| Last Update Posted : | September 28, 2021 |